Budesonide therapy safe, efficacious in the treatment of EoE

Budesonide therapy safe, efficacious in the treatment of EoE

In patients with eosinophilic esophagitis, budesonide oral suspension improved histologic, symptomatic and endoscopic outcomes, according to research published in Clinical Gastroenterology and Hepatology.“Currently, no pharmacologic therapies are approved by the FDA for EoE. As a result, patients often resort to using off-label corticosteroids formulated for asthma leading to suboptimal esophageal delivery and experience difficulties with medical insurance coverage owing to the off-label utilization,” Ikuo Hirano, MD, division of gastroenterology and hepatology at NorthwesternRead More

Share on facebook
Share on twitter
Share on linkedin